BETA Technologies, Inc. (BETA)
22.19
+1.38
(+6.63%)
USD |
NYSE |
Sep 04, 16:00
22.21
+0.02
(+0.09%)
After-Hours: 17:12
BETA Technologies R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical R&D to Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -- |
| March 31, 2026 | -- |
| Date | Value |
|---|---|
| December 31, 2025 | -- |
| September 30, 2025 | -- |
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median